Angiodynamics Stock Today
| ANGO Stock | USD 6.95 0.21 3.12% |
Performance0 of 100
| Odds Of DistressLess than 8
|
AngioDynamics is selling at 6.95 as of the 21st of November 2024; that is 3.12 percent increase since the beginning of the trading day. The stock's open price was 6.74. AngioDynamics has only a 8 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for AngioDynamics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 27th of May 2004 | Category Healthcare | Classification Health Care |
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company has 40.63 M outstanding shares of which 1.23 M shares are presently shorted by private and institutional investors with about 1.67 trading days to cover. More on AngioDynamics
Moving against AngioDynamics Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
AngioDynamics Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO, Director | James Clemmer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Cancer Fighters (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Cancer Fighters, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAngioDynamics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand AngioDynamics' financial leverage. It provides some insight into what part of AngioDynamics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AngioDynamics (ANGO) is traded on NASDAQ Exchange in USA. It is located in 14 Plaza Drive, Latham, NY, United States, 12110 and employs 748 people. AngioDynamics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 273.87 M. AngioDynamics conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 40.63 M outstanding shares of which 1.23 M shares are presently shorted by private and institutional investors with about 1.67 trading days to cover.
AngioDynamics currently holds about 24.56 M in cash with (28.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
Check AngioDynamics Probability Of Bankruptcy
Ownership AllocationAngioDynamics holds a total of 40.63 Million outstanding shares. The majority of AngioDynamics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AngioDynamics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AngioDynamics. Please pay attention to any change in the institutional holdings of AngioDynamics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check AngioDynamics Ownership Details
AngioDynamics Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Armistice Capital, Llc | 2024-06-30 | 836 K | |
| State Street Corp | 2024-06-30 | 789.2 K | |
| Kent Lake Capital Llc | 2024-06-30 | 750 K | |
| Two Sigma Advisers, Llc | 2024-06-30 | 568.7 K | |
| Jacobs Levy Equity Management, Inc. | 2024-06-30 | 509.3 K | |
| Two Sigma Investments Llc | 2024-06-30 | 485.4 K | |
| Paradigm Capital Management, Inc. | 2024-06-30 | 478 K | |
| Jpmorgan Chase & Co | 2024-06-30 | 429.9 K | |
| Assenagon Asset Management Sa | 2024-09-30 | 425.1 K | |
| Blackrock Inc | 2024-06-30 | 4.6 M | |
| Vanguard Group Inc | 2024-09-30 | 2.3 M |
AngioDynamics Historical Income Statement
AngioDynamics Stock Against Markets
Already Invested in AngioDynamics?
The danger of trading AngioDynamics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AngioDynamics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AngioDynamics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AngioDynamics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.07) | Revenue Per Share 7.249 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.78) |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.